Study of a newer cataract surgery device in people with glaucoma
Collects data on a newer cataract surgery device used in people with glaucoma and cataracts.
Plain-language title generated from the registry record
Registry title: Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients
Key facts
- Where
- Geel, BelgiumSee the site
Where in Belgium
- Visionair OogzorgGeel, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Visionair Oogzorg
- Trial code
- NCT06712758
- Record updated
- 2 December 2024
- Original description
You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure.Read full original descriptionShow less
Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients. Prospective, Investigator Initiated and Observational Case Series
You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure.
The aim of this data collection is to demonstrate the safety of a new generation of cataract surgical devices in patients who also suffer from glaucoma. They are glaucoma patients who have an increased sensitivity to eye pressure increases both during and after surgery. The new surgical device makes it possible to safely perform cataract surgery under low pressures. This could, at least theoretically, provide an advantage for patients who also suffer from glaucoma.
Inclusion: Patients diagnosed with glaucoma that are diagnosed with age-related cataract.
Exclusion: Known corticosteroid responder; Presence of uncontrolled systemic disease; Unwilling to sign informed consent; Functionally monophtalmic patient; Endothelial dystrophy; Active uveitis.